Security key
501575104
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR)
CUSIP: 501575104
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 81,496,373
- Total 13F shares
- 80,864,737
- Share change
- +1,985,384
- Total reported value
- $4,576,806,879
- Put/Call ratio
- 40%
- Price per share
- $56.60
- Number of holders
- 207
- Value change
- +$137,276,130
- Number of buys
- 115
- Number of sells
- 92
Report period
Q3 2025
Institutions
207
Top holders
10
KYMR full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Kymera Therapeutics, Inc. SEC filings
Kymera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 501575104
Recent filing periods:
Top shareholders of KYMR - Kymera Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
|
Company · T. Rowe Price Associates, Inc. |
7.1%
from 13D/G
|
6,859,202
|
$299,337,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.4%
from 13D/G
|
4,148,260
|
$181,030,080 | — | 30 Jun 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
8.2%
|
6,651,429
|
$290,268,362 | — | 30 Jun 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
8%
|
6,555,555
|
$286,084,420 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.9%
|
5,619,848
|
$245,250,166 | — | 30 Jun 2025 | |
| BVF INC/IL |
13F
|
Company |
6.8%
|
5,502,710
|
$240,138,264 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
6.7%
|
5,431,994
|
$237,052,223 | — | 30 Jun 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.6%
|
5,372,061
|
$234,436,742 | — | 30 Jun 2025 | |
| Atlas Venture Life Science Advisors, LLC |
13F
|
Company |
6%
|
4,896,462
|
$213,681,602 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
4.2%
|
3,428,150
|
$149,604,466 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.9%
|
1,554,431
|
$67,835,369 | — | 30 Jun 2025 | |
| Capital Research Global Investors |
13F
|
Company |
1.5%
|
1,262,182
|
$55,081,622 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,193,112
|
$52,075,233 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
933,890
|
$40,754,960 | — | 30 Jun 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1%
|
825,025
|
$36,004,090 | — | 30 Jun 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1%
|
818,927
|
$35,737,975 | — | 30 Jun 2025 | |
| Redmile Group, LLC |
13F
|
Company |
0.99%
|
803,289
|
$35,055,532 | — | 30 Jun 2025 | |
| Merck & Co., Inc. |
13F
|
Company |
0.95%
|
772,165
|
$33,697,281 | — | 30 Jun 2025 | |
| Commodore Capital LP |
13F
|
Company |
0.92%
|
750,000
|
$32,730,000 | — | 30 Jun 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.8%
|
653,000
|
$28,496,920 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.69%
|
563,365
|
$24,587,428 | — | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.69%
|
562,990
|
$24,568,884 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.68%
|
557,734
|
$24,339,512 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.64%
|
518,887
|
$22,644,229 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.61%
|
498,111
|
$21,737,564 | — | 30 Jun 2025 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.6%
|
491,810
|
$21,462,588 | — | 30 Jun 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.6%
|
487,961
|
$21,294,618 | — | 30 Jun 2025 | |
| AJU IB Investment Co., Ltd. |
13F
|
Company |
0.56%
|
457,059
|
$19,946,055 | — | 30 Jun 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.55%
|
450,374
|
$19,654,321 | — | 30 Jun 2025 | |
| Boxer Capital Management, LLC |
13F
|
Company |
0.53%
|
432,010
|
$18,852,916 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.53%
|
429,304
|
$18,734,827 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.5%
|
409,353
|
$17,864,164 | — | 30 Jun 2025 | |
| Nextech Invest, Ltd. |
13F
|
Company |
0.42%
|
340,909
|
$14,877,269 | — | 30 Jun 2025 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.4%
|
329,020
|
$14,358,433 | — | 30 Jun 2025 | |
| Deer Management Co. LLC |
13F
|
Company |
0.4%
|
325,895
|
$14,222,058 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.37%
|
304,200
|
$13,275,288 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
278,736
|
$12,164,039 | — | 30 Jun 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.34%
|
275,000
|
$12,001,000 | — | 30 Jun 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.33%
|
269,284
|
$11,751,553 | — | 30 Jun 2025 | |
| Octagon Capital Advisors LP |
13F
|
Company |
0.33%
|
266,000
|
$11,608,240 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.31%
|
250,000
|
$10,910,000 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.29%
|
237,605
|
$10,369,107 | — | 30 Jun 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
234,970
|
$10,254,091 | — | 30 Jun 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.28%
|
224,300
|
$9,788,452 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.26%
|
210,106
|
$9,169,026 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.25%
|
207,722
|
$9,064,988 | — | 30 Jun 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.23%
|
184,478
|
$8,050,620 | — | 30 Jun 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
162,315
|
$7,083,427 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.2%
|
159,163
|
$6,945,873 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.19%
|
156,253
|
$6,819,000 | — | 30 Jun 2025 |
Institutional Holders of Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) as of Q3 2025
As of 30 Sep 2025,
Kymera Therapeutics, Inc. - COMMON STOCK (KYMR) was held by
207 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
80,864,737 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, FMR LLC, BVF INC/IL, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Atlas Venture Life Science Advisors, LLC, BlackRock, Inc., and Siren, L.L.C..
This page lists
207
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
208
Q3 2025 holders
207
Holder diff
-1
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.